Wilmington Savings Fund Society’s iShares Biotechnology ETF IBB Stock Holding History

Wilmington Savings Fund Society’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$119K	Hold	628	–	–	﹤0.01%	706
2026 Q1	$106K	Hold	628	–	–	﹤0.01%	726
2025 Q4	$106K	Hold	628	–	–	﹤0.01%	724
2025 Q3	$90.7K	Sell	628 -943	-60%	-$129K	﹤0.01%	753
2025 Q2	$199K	Buy	1,571 +467	+42%	+$57.3K	﹤0.01%	805
2025 Q1	$141K	Sell	1,104 -82	-7%	-$11.1K	﹤0.01%	903
2024 Q4	$157K	Sell	1,186 -623	-34%	-$87.6K	﹤0.01%	910
2024 Q3	$263K	Buy	+1,809	New	+$262K	﹤0.01%	733

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Wilmington Savings Fund Society's IBB Position: Q2 2026 in Review

Wilmington Savings Fund Society held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 628 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Wilmington Savings Fund Society first reported a position in IBB in Q3 2024 and has held it in 8 quarters since. The position peaked at $263K in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Wilmington Savings Fund Society held 628 shares of iShares Biotechnology ETF worth $119K as of Q2 2026.
Wilmington Savings Fund Society left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #706 holding.
Wilmington Savings Fund Society first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 8 quarters since.
Wilmington Savings Fund Society's iShares Biotechnology ETF position peaked at $263K in Q3 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.